Top Page
Dexin Services Group Ltd.
(2215)
Dexin Services Group Ltd. (2215) vs. iShares MSCI Hong Kong ETF (EWH)
Dexin Services Group Ltd. Business Overview & Revenue Model
Dexin Services Group Ltd. Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 933.42M | 955.58M | 958.60M | 870.42M | 692.32M |
| Gross Profit | 187.60M | 226.04M | 271.37M | 299.08M | 235.76M |
| EBITDA | 64.95M | 96.12M | 173.07M | 157.27M | 146.58M |
| Net Income | 38.47M | 61.77M | 122.02M | 98.22M | 97.19M |
Balance Sheet | |||||
| Total Assets | 1.34B | 1.42B | 1.31B | 1.24B | 444.94M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 501.21M | 2.11M | 499.98M | 232.75M |
| Total Debt | 17.18M | 28.11M | 57.22M | 3.99M | 5.55M |
| Total Liabilities | 650.87M | 665.62M | 533.69M | 378.33M | 356.51M |
| Stockholders Equity | 680.93M | 742.77M | 764.54M | 835.66M | 75.87M |
Cash Flow | |||||
| Free Cash Flow | 10.00M | 133.27M | -231.53M | -5.89M | 250.28M |
| Operating Cash Flow | 12.95M | 141.53M | -223.57M | 3.13M | 258.35M |
| Investing Cash Flow | 81.14M | -6.25M | 85.79M | -140.33M | 65.27M |
| Financing Cash Flow | -121.64M | -115.41M | -152.35M | 407.97M | -199.16M |
Dexin Services Group Ltd. Technical Analysis
Dexin Services Group Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$903.87M | 7.18 | 9.14% | 7.08% | 13.57% | -11.39% | |
75 Outperform | HK$443.01M | 4.25 | 8.37% | 4.86% | -14.98% | -39.71% | |
66 Neutral | HK$1.27B | 29.04 | 12.90% | ― | 31.21% | 1.00% | |
62 Neutral | HK$537.60M | 8.74 | 7.83% | ― | 1.96% | -32.15% | |
59 Neutral | HK$578.27M | 14.09 | 5.41% | ― | -4.12% | -38.34% | |
54 Neutral | HK$698.56M | 22.26 | 1.38% | 5.29% | -11.10% | -40.00% | |
53 Neutral | $1.23B | 2.70 | -5.63% | 5.63% | -2.28% | -110.71% |
Dexin Services Group Ltd. Corporate Events
Dexin Services Group Limited has announced a board meeting scheduled for August 26, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025, and to consider the recommendation of an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential dividend payouts, impacting investor expectations and market positioning.
Dexin Services Group Ltd. has announced a significant transaction involving the acquisition of equity interests in a target company through its subsidiaries, Shengquan Property and Shanghai Xuquan. This acquisition, valued at RMB78 million, will result in the target company becoming an indirect wholly-owned subsidiary of Dexin Services, thereby consolidating its financial results into Dexin’s statements. The acquisition aligns with Dexin’s strategic goals of expanding its business scale, diversifying into more profitable areas, and enhancing brand recognition. The transaction will be funded through a combination of unutilized net proceeds from a previous global offering and internal resources.
Dexin Services Group Limited has announced changes in the composition of its Nomination Committee in response to the amended Corporate Governance Code and listing rules effective from July 2025. Ms. Zheng Peng has been appointed as a member, while Mr. Hu Yiping has stepped down as chairman and member, with Dr. Wong Wing Kuen Albert taking over as chairman. These changes aim to align with updated governance standards, potentially impacting the company’s governance structure and stakeholder confidence.
Dexin Services Group Limited has announced the composition of its board of directors and their respective roles within the company. The board includes both executive and independent non-executive directors, with specific members assigned to key committees such as the Audit, Remuneration, and Nomination Committees. This announcement highlights the company’s governance structure, which is crucial for maintaining transparency and accountability, potentially impacting stakeholder confidence and the company’s strategic direction.
Dexin Services Group Limited has outlined the terms of reference for its Nomination Committee, which is established by the company’s board of directors. The committee is primarily composed of independent non-executive directors and is responsible for overseeing the nomination process within the company. The announcement highlights the committee’s structure, meeting protocols, and decision-making processes, emphasizing the inclusion of diverse gender representation and the flexibility of meeting attendance through electronic means. This move is likely aimed at enhancing governance and ensuring a robust nomination process, which could positively impact the company’s strategic direction and stakeholder confidence.
Dexin Services Group Limited has outlined the terms of reference for its Remuneration Committee, which is to be comprised mainly of independent non-executive directors. The committee will be chaired by an independent non-executive director and is responsible for meeting at least once a year, with resolutions requiring a majority vote to pass. The establishment of this committee aims to enhance governance and ensure fair remuneration practices within the company.
Dexin Services Group Ltd. announced that all ordinary resolutions proposed at their Annual General Meeting held on May 29, 2025, were unanimously passed by shareholders. Key resolutions included the adoption of audited financial statements, re-election of executive directors, authorization of board remuneration, re-appointment of auditors, and granting of mandates for share issuance and buybacks. This unanimous approval reflects strong shareholder support and may positively impact the company’s governance and operational strategies.